Reperfusion syndrome

Surgical approach (typical scenarios where reperfusion syndrome occurs)

  • Aortic cross-clamping and release (open AAA repair; thoracoabdominal aneurysm repair)
    • Clamp applied proximal to aneurysm → ischaemia distal to clamp; clamp release → sudden washout of metabolites + haemodynamic collapse risk
    • May use sequential/partial unclamping; may request permissive hypotension during clamp release depending on bleeding risk
  • Lower limb revascularisation (embolectomy, bypass, thrombectomy, angioplasty/stenting for acute limb ischaemia)
    • Reperfusion of ischaemic muscle → hyperkalaemia, acidosis, myoglobin release, compartment syndrome
  • Liver transplantation (reperfusion phase after portal vein unclamp)
    • Graft reperfusion → abrupt fall in SVR/MAP, bradyarrhythmias, hyperkalaemia, acidosis; may be exacerbated by cold/preserved graft flush
  • Tourniquet release (orthopaedics)
    • Transient hypotension, acidosis, rise in EtCO2, hyperkalaemia (usually mild unless prolonged/large muscle mass/ischaemia)

Anaesthetic management (practical template for cases with reperfusion risk)

  • Type of anaesthesia
    • GA for major vascular surgery, transplantation; regional/GA+regional may be used for limb revascularisation depending on urgency/anticoagulation
    • Neuraxial techniques may be limited by anticoagulation, haemodynamic instability, and surgical urgency
  • Airway
    • ETT preferred (controlled ventilation, rapid changes in CO2/acid-base, large fluid shifts, potential massive transfusion)
    • SGA generally inappropriate for major vascular/transplant; may be acceptable for short low-risk tourniquet cases
  • Duration
    • Open AAA: often 2–4+ hours; thoracoabdominal: longer; limb revascularisation: 1–4 hours; liver transplant: 6–12+ hours
  • Pain
    • Multimodal analgesia; consider epidural for open AAA if not contraindicated (institution-dependent) and haemostasis acceptable
    • Limb revascularisation: significant postoperative pain; consider regional blocks if anticoagulation allows
  • Monitoring and access
    • Arterial line before induction if unstable; large-bore IV access; central venous access often for major cases; consider cardiac output monitoring (context-specific)
    • Frequent ABG/VBG: K+, pH, lactate, ionised Ca2+, Hb, glucose
    • Temperature monitoring and active warming (hypothermia worsens acidosis/coagulopathy/arrhythmias)
  • Preparation specifically for reperfusion
    • Communicate timing; ensure adequate preload but avoid overload; optimise Hb/oxygen delivery
    • Correct acidosis and hyperkalaemia as far as possible; ensure calcium available; vasopressors/inotropes drawn up and running if needed
    • Increase minute ventilation shortly before release if rising CO2/acidosis expected (tourniquet; major reperfusion)
  • Immediate management at reperfusion
    • Hypotension: vasopressor boluses (metaraminol/phenylephrine) and/or infusion (noradrenaline); consider adrenaline if myocardial depression/bradycardia
    • Bradyarrhythmia: atropine/glycopyrrolate; adrenaline if severe; pacing rarely
    • Hyperkalaemia: calcium chloride, insulin+dextrose, sodium bicarbonate if acidotic, hyperventilation, beta-agonist; consider dialysis/haemofiltration in transplant/renal failure
    • Acidosis: improve perfusion/ventilation; bicarbonate selectively (severe metabolic acidosis with haemodynamic compromise)
    • Consider pulmonary embolic load (tourniquet: microemboli; cement; thrombus) if sudden RV failure/hypoxia
  • Postoperative care
    • Ongoing monitoring for rhabdomyolysis, AKI, compartment syndrome, coagulopathy, arrhythmias, reperfusion pulmonary oedema/ARDS
    • Maintain urine output; consider mannitol/alkalinisation only in selected rhabdomyolysis protocols; early renal support if needed

Definition and clinical contexts

  • Reperfusion syndrome = haemodynamic instability and metabolic/inflammatory consequences following restoration of blood flow to previously ischaemic tissue
  • Common anaesthetic contexts: aortic cross-clamp release, acute limb ischaemia revascularisation, liver transplantation (post-reperfusion syndrome), tourniquet deflation

Pathophysiology (high-yield mechanisms)

  • Washout of metabolites from ischaemic tissue
    • Metabolic acidosis (lactate), hyperkalaemia, increased CO2 load → ↑EtCO2 after tourniquet release
  • Systemic vasodilation and relative hypovolaemia
    • Abrupt fall in MAP at unclamping/reperfusion; worsened by anaesthetic depth, hypothermia, pre-existing hypovolaemia
  • Myocardial depression and arrhythmogenesis
    • Hyperkalaemia/acidosis + inflammatory mediators → bradyarrhythmias, VF/VT risk in severe cases
  • Inflammatory and endothelial injury
    • Reactive oxygen species, cytokines, complement activation → capillary leak, pulmonary dysfunction, organ injury
  • Microvascular dysfunction and no-reflow phenomenon
    • Despite macroscopic reperfusion, microcirculatory obstruction (endothelial swelling, leukocyte plugging, microthrombi) can perpetuate tissue injury
  • Rhabdomyolysis-related effects (especially limb ischaemia)
    • Myoglobinuria, hyperkalaemia, hypocalcaemia (early), AKI; risk increases with prolonged ischaemia and large muscle mass

Clinical features (what you see at reperfusion)

  • Haemodynamic: sudden hypotension (↓SVR ± ↓CO), bradycardia; may progress to cardiac arrest if severe
  • Respiratory/ventilation: rise in EtCO2 (tourniquet release), hypoxia if pulmonary dysfunction/embolisation
  • Metabolic: hyperkalaemia, metabolic acidosis, rising lactate; hypocalcaemia may occur (citrate load/transfusion; rhabdo dynamics)
  • Renal/muscle: dark urine (myoglobin), oliguria/AKI; swollen tense limb (compartment syndrome)

Risk factors

  • Prolonged ischaemia time; large ischaemic tissue mass (aortic clamp, major limb, liver graft); poor collateral circulation
  • Pre-existing metabolic derangement: acidosis, hyperkalaemia, renal failure; sepsis; hypothermia
  • Cardiac disease: poor LV function, pulmonary hypertension/RV dysfunction; limited physiological reserve
  • Liver transplant-specific: marginal graft, prolonged cold/warm ischaemia, high K+ in preservative flush, severe portal hypertension

Differential diagnosis of sudden collapse at unclamping/reperfusion

  • Bleeding (surgical), anaesthetic overdose, anaphylaxis, myocardial ischaemia, tamponade (rare), tension pneumothorax
  • Embolic phenomena: pulmonary embolus (thrombus/air/fat), cement implantation syndrome (orthopaedics)
  • Hyperkalaemic arrest from transfusion error/rapid K+ load; citrate toxicity/hypocalcaemia during massive transfusion

Prevention strategies (peri-reperfusion bundle)

  • Planning and communication: confirm timing of clamp/tourniquet release; ask for gradual/partial release where feasible
  • Optimise physiology: normothermia; adequate preload; maintain coronary perfusion; avoid excessive anaesthetic depth at release
  • Correct/anticipate metabolic issues: check ABG; treat rising K+; increase ventilation before release; ensure calcium available
  • Vasoactive readiness: noradrenaline infusion prepared; bolus vasopressors drawn up; consider inotrope if poor LV function
  • Transfusion/coagulation: anticipate major bleeding; use cell salvage if appropriate; monitor ionised calcium and give calcium during massive transfusion

Immediate treatment (structured approach)

  • A–E and call for help; confirm event timing (immediately after reperfusion?)
  • Haemodynamics: treat hypotension with vasopressors; give fluid bolus if preload responsive; consider adrenaline if severe myocardial depression/bradycardia
  • Ventilation: increase minute ventilation; 100% oxygen; assess for sudden RV strain/hypoxia suggesting embolic cause
  • Metabolic: urgent ABG; treat hyperkalaemia (calcium chloride, insulin/dextrose, bicarbonate if severe acidosis, salbutamol); correct hypocalcaemia
  • If arrest: ALS with attention to reversible causes (hyperkalaemia, severe acidosis, hypovolaemia/bleeding, embolus)

Complications to anticipate after reperfusion

  • Arrhythmias, myocardial ischaemia, low cardiac output state
  • AKI (myoglobin, hypotension, inflammatory injury); need for RRT
  • Coagulopathy (dilutional, hypothermia, acidosis; transplant-specific), bleeding
  • Compartment syndrome after limb reperfusion (pain out of proportion, tense compartments, neurovascular compromise) → urgent fasciotomy
  • Pulmonary complications: reperfusion pulmonary oedema/ARDS
You are anaesthetising an open AAA repair. The surgeon warns you they will release the aortic cross-clamp in 2 minutes. What do you do?

Aim: anticipate hypotension, acidosis, hyperkalaemia, and sudden changes in preload/afterload.

  • Confirm timing and request controlled/partial unclamping if feasible
  • Optimise haemodynamics: ensure adequate preload (judicious fluid bolus if indicated), reduce volatile/anaesthetic depth slightly, ensure MAP adequate for coronary perfusion
  • Vasoactive drugs ready: noradrenaline running or immediately available; bolus vasopressor drawn up; consider adrenaline if poor LV function
  • Ventilation: increase minute ventilation shortly before release to buffer CO2 load; ensure 100% oxygen at release
  • Metabolic preparation: check recent ABG (K+, pH, lactate, ionised Ca2+); treat hyperkalaemia/acidosis if present; ensure calcium chloride available
  • Blood and coagulation: ensure blood products available; monitor ionised calcium during transfusion; temperature management
Immediately after unclamping the aorta the BP falls from 120/70 to 55/30 with bradycardia. EtCO2 rises. Give a structured differential diagnosis and immediate management.

Treat first, diagnose in parallel; timing strongly suggests reperfusion but exclude catastrophic bleeding/embolus/anaphylaxis.

  • Differential diagnosis
    • Reperfusion syndrome: ↓SVR, washout (acidosis/hyperkalaemia), myocardial depression
    • Major haemorrhage (surgical bleeding at anastomosis), hypovolaemia
    • Myocardial ischaemia/infarction, arrhythmia
    • Embolic event (air/thrombus) causing RV failure; less likely with isolated ↑EtCO2 but consider if hypoxia/RV strain
    • Anaphylaxis (look for bronchospasm, rash, rising airway pressures)
  • Immediate management
    • A–E; 100% oxygen; check pulse/rhythm; call for help; ask surgeon to assess bleeding and consider re-clamping/partial clamp if appropriate
    • Vasopressors: bolus metaraminol/phenylephrine; start/increase noradrenaline infusion; if severe bradycardia/low output give adrenaline bolus and consider infusion
    • Fluid bolus if preload responsive; rapid transfusion if bleeding suspected
    • ABG urgently: treat hyperkalaemia (calcium chloride first if ECG changes/instability), insulin/dextrose, bicarbonate if severe acidosis; increase ventilation
    • 12-lead/echo if available; consider TEE in major vascular/transplant settings to differentiate LV failure vs RV failure vs hypovolaemia
Describe the pathophysiology of reperfusion injury and how it differs from simple 'washout'.

Two overlapping processes: (1) washout of metabolites causing acute systemic effects; (2) reperfusion injury causing ongoing cellular/endothelial damage.

  • Washout effects (immediate systemic physiology)
    • Acidic, hyperkalaemic, CO2-rich blood returns to central circulation → hypotension, arrhythmias, ↑EtCO2
  • Reperfusion injury (cellular/inflammatory)
    • Reactive oxygen species generation on reoxygenation; mitochondrial dysfunction
    • Endothelial activation, neutrophil adhesion, complement → capillary leak, microthrombi, no-reflow
    • Calcium influx and cell swelling → apoptosis/necrosis; contributes to organ dysfunction beyond initial washout
In liver transplantation, what is post-reperfusion syndrome (PRS) and how do you manage it?

PRS is a reperfusion-related cardiovascular collapse occurring immediately after graft reperfusion.

  • Definition (commonly used): fall in MAP ≥30% from baseline lasting ≥1 minute within the first 5 minutes after reperfusion (definitions vary by centre)
  • Mechanisms: ↓SVR, myocardial depression, hyperkalaemia/acidosis from preservative and washout, hypocalcaemia (citrate), hypothermia, air/particulate emboli
  • Preparation: ABG and K+ pre-reperfusion; ensure calcium ready; vasopressors/inotropes prepared; communicate reperfusion timing; consider flushing strategy per surgical team
  • Treatment: noradrenaline/vasopressin for vasoplegia; adrenaline if myocardial depression/bradycardia; treat hyperkalaemia (calcium chloride first if unstable), correct acidosis/ventilation, correct ionised calcium
A patient with acute limb ischaemia undergoes femoral embolectomy. After reperfusion they develop peaked T waves and hypotension. Outline your management and postoperative concerns.

Think hyperkalaemia + acidosis + rhabdomyolysis; treat immediately and anticipate complications.

  • Immediate management
    • 100% oxygen, confirm rhythm, urgent ABG (K+, pH, lactate, Ca2+)
    • Hyperkalaemia: calcium chloride IV, insulin/dextrose, consider sodium bicarbonate if acidotic, nebulised/IV beta-agonist; increase ventilation
    • Support BP: vasopressor boluses and/or noradrenaline infusion; fluid if responsive
  • Postoperative concerns
    • Rhabdomyolysis: CK, myoglobinuria; maintain renal perfusion; early renal support if AKI/hyperkalaemia refractory
    • Compartment syndrome: escalating pain, tense compartments, neurological deficit → urgent assessment/fasciotomy
    • Ongoing metabolic derangement and arrhythmias: HDU/ICU monitoring
Tourniquet deflation: what physiological changes do you expect and what factors make them worse?

Usually transient; more pronounced with prolonged inflation and large muscle mass.

  • Expected changes
    • Transient fall in MAP/SVR; rise in EtCO2; mild metabolic acidosis; small rise in K+; increased venous return of metabolites
  • Worsening factors
    • Prolonged tourniquet time, high pressure, large limb/muscle mass, pre-existing renal failure/acidosis, hypovolaemia
  • Management
    • Increase minute ventilation around deflation; ensure adequate analgesia/anaesthetic depth; treat hypotension with vasopressors/fluids as needed; check electrolytes if high risk
Previous FRCA-style: 'Discuss the causes of hypotension on release of an aortic cross-clamp and how you would manage it.'

Structure: causes (physiology + pathology) then management (prevention + treatment).

  • Causes
    • Sudden ↓SVR due to reperfusion vasodilation and release of vasoactive mediators
    • Relative hypovolaemia: blood pooled in dilated distal vascular bed; ongoing bleeding
    • Myocardial depression: acidosis/hyperkalaemia, ischaemia, reduced coronary perfusion pressure
    • Arrhythmias due to electrolyte/acid-base disturbance
  • Management
    • Pre-empt: communication, partial unclamping, optimise preload, reduce anaesthetic depth, vasopressors ready, ABG check
    • Treat: vasopressor boluses and noradrenaline infusion; fluid/blood if hypovolaemia/bleeding; treat hyperkalaemia and acidosis; consider inotrope if low CO
    • Reassess: bleeding, ECG/echo, temperature, ionised calcium, lactate; escalate to ICU
Previous FRCA-style: 'Outline the metabolic consequences of reperfusion of an ischaemic limb and their anaesthetic implications.'

Think K+, acid, myoglobin, calcium shifts, renal injury; implications are monitoring and rapid treatment.

  • Metabolic consequences
    • Hyperkalaemia from cell lysis and washout
    • Metabolic acidosis and raised lactate
    • Rhabdomyolysis → myoglobinuria → AKI
    • Calcium/phosphate disturbances (context-dependent; hypocalcaemia may occur early in rhabdo; citrate from transfusion may contribute)
  • Anaesthetic implications
    • Invasive monitoring; frequent ABGs; readiness to treat hyperkalaemia; avoid potassium-containing fluids in high-risk cases
    • Maintain perfusion pressure; consider ICU; plan for renal support if refractory hyperkalaemia/AKI
    • Vigilance for compartment syndrome; ensure good postoperative analgesia and regular limb assessment

0 comments